Every day, over 34 people in the UK are diagnosed with head and neck cancer, growing 30% per decade. Only 13% catch it early. Oracle Head & Neck Cancer UK urges political parties to back a long-term cancer strategy for better outcomes. #OneCancerVoice

A revolt over patient safety and declining expertise is tearing the medical establishment apart. 🖊️ @pwhitakerwriter newstatesman.com/long-reads/202…

The Guardian view on Keynesian naivety: workers must be able to bargain for a fair share | Editorial theguardian.com/commentisfree/…

Head & Neck cancer patients face the longest waits of all cancer types. Just over half start treatment within the 62-day target, according to research from Cancer Research UK Policy highlighted by the BBC tinyurl.com/338w5aup. Read BAHNO Head & Neck response here: tinyurl.com/mr296u9k

A summary of the ADC session at #UromigosLive24 with Andrea Apolo, M.D. Shilpa Gupta Petros Grivas Tom Powles & KSridhar

Very much hoping to be part of this, to develop guidelines for helping people with the late effects of head & neck radiotherapy. Please retweet / sign up if you’re interested! National Oncology Trainees Research Collaborative David Cutter Ben O'Leary David Thomson

📢Calling all SAS doctors in England📢 We want to hear from you about how we can improve your workplace experience. Complete our survey by 13 November to ensure your voice is included.👇👇 surveymonkey.com/r/WorkplaceExp…

📢First 'Atlas of health variation in Head and Neck Cancers in England' .NDRS Data 2013 to 2019 pre-pandemic and 2020 post pandemic. zmarshman Office for Health Improvement and Disparities Full access to atlas PDF and interactive atlas tool via link below: gov.uk/government/sta…

🧐Our DEPEND trial is out! Neoadjuvant nivo/chemo followed by response-stratified CRT in HPV-negative stage IVa/b HNSCC. UChicagoCancerCenter University of Chicago Hematology/Oncology Aditya Juloori Pearson Lab Nishant Agrawal Evgeny Izumchenko Everett Vokes jamanetwork.com/journals/jamao…

April is Head and Neck Cancer Awareness Month! Help spread awareness and share/repost some "Facts to Know" about a common Head and Neck Cancer - HPV-related Oropharyngeal Cancer #HPV ~ AHNS Patient & Public Education Service #AHNS #headandneckcancer #headandneckcancerawareness

Limited tickets for the 3rd Annual Meeting of The International Centre for Recurrent Head & Neck Cancer are still available. Why not make the most of your BAHNO week by starting a day early! 🧠 CPD Accredited. From £65 📅 15May2025 📍London 🔗 bahnomeeting.com/bahno-conferen…

Great day at BAHNO Head & Neck with the Leicester Head and Neck Oncology #BAHNO2025

The KEYNOTE-689 trial received its highly anticipated second global airing at BAHNO Head & Neck annual scientific meeting, presented by Professor Kevin Harrington, reaffirming its potential to redefine the standard of care in resectable head and neck cancer. #BAHNO2025

Systems are crumbling - but daily life continues. The dissonance is real theguardian.com/wellness/ng-in…

Boom!💥 ⁦FDA⁩ approves neoadjuvant and adjuvant pembrolizumab for resectable locally advanced head and neck squamous cell carcinoma, ushering in a new standard of care for the first time in decades. fda.gov/drugs/resource…

Diagnosis and treatment of radiation induced pneumonitis in patients with #lungcancer: An ESTRO clinical practice #guideline, published in Radiotherapy & Oncology. 👉 Read it before your patients: bit.ly/4kxWglQ #radonc

Dual Targeting in #HNSCC! Dr.Ari Rosenberg of @Uchicago presents petosemtamab data—ORR 36%, mPFS 4.9m as monotherapy in 2L+ HNSCC; combo with pembrolizumab in 1L PD-L1+ shows 63% ORR, 12-mo OS 79%. Phase 3 LiGeR-HN trials underway. #DAVALung #Oncology

Dual Targeting in HNSCC | Dr.Ari Rosenberg of @Uchicago: Amivantamab (EGFR/MET bispecific) shows 55x potency vs mono-Abs (IC50 0.64nM); OrigAMI-4 trials test combos incl. amivantamab+pembro+carbo in R/M HNSCC. #DAVALung #HNSCC #Immunotherapy

Humbled & Honoured to be the next President of British Society of Head & Neck Imaging British Society of Head & Neck Imaging Huge thank you to Ravi Kumar Lingam & rest of the BSHNI Council 2023-2025 for their stellar work Look forward to working with the new council members as we continue the good work